Endo Pharma

SUPPRELIN LA

Manufacturer:

Endo Pharma

Supprelin La HCPCS:

J9226

HCPCS Code Descriptor:

Histrelin implant (supprelin la), 50 mg

Category:

J Code

Supprelin La NDCs:

67979-0002-01

Primary Type:

Growth Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Subcutaneous

Supprelin La CPT Codes:

Potential CPT administration codes for Supprelin La can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Supprelin La:

SUPPRELIN LA is a Growth Disorder drug manufactured by Endo Pharma and administered via the Subcutaneous route of administration. The J Code: J9226 is aligned to the drug SUPPRELIN LA.

ACCESS PRICING AND MORE BY REGISTERING

J9226 Added Date:

January 1, 2008

J9226 Effective Date:

January 1, 2023

J9226 Termination Date:

HCPCS Active

Supprelin La billing and coding information can be found through Endo Pharma at the link below:
Supprelin La patient assistance information can be found through Endo Pharmaceuticals at the URL: http://www.supprelinla.com/support-center-and-savings.aspx
SUPPRELIN LA prescribing information can be found at the link below:
Information regarding SUPPRELIN LA’s side effects can be found at MedlinePlus